Mitigation of the Oxidative Damage in Liver Caused by Influenza Virus Infection in Mice by an Effective Combination of Oseltamivir and S-adenosyl-L-methionine (SAM)

Q3 Pharmacology, Toxicology and Pharmaceutics Journal of Pharmacy and Nutrition Sciences Pub Date : 2022-12-31 DOI:10.29169/1927-5951.2022.12.11
M. Mileva, Adriana Dimitrova-Koleva, E. Tsvetanova, D. Krastev, A. Georgieva, A. Alexandrova, A. Galabov
{"title":"Mitigation of the Oxidative Damage in Liver Caused by Influenza Virus Infection in Mice by an Effective Combination of Oseltamivir and S-adenosyl-L-methionine (SAM)","authors":"M. Mileva, Adriana Dimitrova-Koleva, E. Tsvetanova, D. Krastev, A. Georgieva, A. Alexandrova, A. Galabov","doi":"10.29169/1927-5951.2022.12.11","DOIUrl":null,"url":null,"abstract":"\nThis study aimed to estimate the protective effect of a combination of S-Adenosyl-L-methionine (SAM) as a precursor of glutathione and oseltamivir as a specific inhibitor of virus replication on oxidative damages caused by influenza infection in the liver of infected mice. Albino mice were inoculated with 10×LD50 of influenza virus A/Aichi/2/68(H3N2). Oseltamivir was applied for five days after infection, twice per day, in a dose of 2.5 mg/kg. SAM was applied for ten days in a 100 mg/kg dose, starting five days before inoculation. Markers of oxidative stress, mortality rate, mean survival time, index, and protection coefficient were followed. Influenza infection causes severe oxidative damage to the liver. All combinations of SAM and oseltamivir restored the levels of the biochemical markers to those in healthy animals and improved the virological parameters. A combination of SAM 100 mg/kg and oseltamivir 2.5 mg/kg, which is 1/4 of the optimal therapeutic mice dose, exhibits protection index and affects most effectively all the tested parameters. This study provides an easy-to-apply approach with a good therapeutic potential for co-medicating influenza infection with a specific antiviral agent and an antioxidant precursor.\n","PeriodicalId":16959,"journal":{"name":"Journal of Pharmacy and Nutrition Sciences","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy and Nutrition Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29169/1927-5951.2022.12.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

This study aimed to estimate the protective effect of a combination of S-Adenosyl-L-methionine (SAM) as a precursor of glutathione and oseltamivir as a specific inhibitor of virus replication on oxidative damages caused by influenza infection in the liver of infected mice. Albino mice were inoculated with 10×LD50 of influenza virus A/Aichi/2/68(H3N2). Oseltamivir was applied for five days after infection, twice per day, in a dose of 2.5 mg/kg. SAM was applied for ten days in a 100 mg/kg dose, starting five days before inoculation. Markers of oxidative stress, mortality rate, mean survival time, index, and protection coefficient were followed. Influenza infection causes severe oxidative damage to the liver. All combinations of SAM and oseltamivir restored the levels of the biochemical markers to those in healthy animals and improved the virological parameters. A combination of SAM 100 mg/kg and oseltamivir 2.5 mg/kg, which is 1/4 of the optimal therapeutic mice dose, exhibits protection index and affects most effectively all the tested parameters. This study provides an easy-to-apply approach with a good therapeutic potential for co-medicating influenza infection with a specific antiviral agent and an antioxidant precursor.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
奥司他韦与s -腺苷- l-蛋氨酸联合有效减轻流感病毒感染小鼠肝脏氧化损伤
本研究旨在评估s -腺苷- l-甲硫氨酸(SAM)(谷胱甘肽前体)和奥司他韦(病毒复制特异性抑制剂)联合使用对流感感染小鼠肝脏氧化损伤的保护作用。用流感病毒A/爱知/2/68(H3N2) 10×LD50接种白化病小鼠。奥司他韦在感染后使用5天,每天两次,剂量为2.5 mg/kg。接种前5天开始,以100 mg/kg剂量施用10天。观察氧化应激指标、死亡率、平均生存时间、指数和保护系数。流感感染会对肝脏造成严重的氧化损伤。SAM和奥司他韦的所有组合都使生化标志物水平恢复到健康动物的水平,并改善了病毒学参数。沙参100 mg/kg与奥司他韦2.5 mg/kg的组合剂量为最佳治疗小鼠剂量的1/4,显示出保护指数,对所有试验参数的影响最有效。这项研究提供了一种易于应用的方法,与特定的抗病毒药物和抗氧化前体共同治疗流感感染具有良好的治疗潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Pharmacy and Nutrition Sciences
Journal of Pharmacy and Nutrition Sciences Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
自引率
0.00%
发文量
0
期刊最新文献
Assessing the Efficacy of Natural Pet Products in Protecting Gastric Cells and Reducing Cytotoxicity under Hyperacidity Conditions: An In Vitro Study Antioxidant Effect of a Combination of S-Acetyl-L-Glutathione, Vitamin E, Silybum Marianumon Hepatic Cells under Oxidative Stress: An In Vitro Study Protective Effect of Curcuminoids Consumption on Cadmium-Induced Testicular Injury in Albino Rats Clinical Trial: Management of Post-Haemorrhoidectomy Wound Healing by Bergamot Flavonoid-Based Gel and Sodium Hyaluronate: An Observational, Multicentric Trial Acid Suppressant Activity of Feed Dietary Supplements for Dogs
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1